Evidence map›Paper›PMID 42483622›Full record

ReviewPrzeglad gastroenterologiczny2026

Health benefits of oat dietary fibre in inflammatory bowel disease: a systematic review.

Vanda Sargautiene

Abstract readReview
In one paragraph

Review in Przeglad gastroenterologiczny, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Vanda SargautieneFaculty of Medicine and Life Sciences, University of Latvia, Latvia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Oats are well-known for their health benefits in managing chronic diseases, mainly due to their fibre content, especially b-glucan, which has prebiotic properties. Aim: This review aimed to examine clinical and preclinical studies conducted in the past decade on the effects of oat dietary fibre, particularly b-glucan, in the context of inflammatory bowel disease (IBD). Methods: A systematic search of the PubMed, Scopus, and Web of Sciences databases from 2014 to 2024 was performed using the keywords (oat Results: The search identified 159 studies, of which 20 met the inclusion criteria. Two clinical trials, 1 case-control study, and one Conclusions: The findings emphasize the need for more clinical trials to further explore the potential of oat dietary fibre in treating IBD.

Indexed as

Crohn’s diseaseinflammatory bowel diseaseoat b-glucanoatsulcerative colitis

Identifiers

PMID42483622
PMCPMC13386255

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.